Trial Profile
A study to evaluate the LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 05 Feb 2016 New trial record